Published January 15, 1979 | Version v1
Patent Open

Specific binding assay technique; standardization of reagent

Description

The standardization of a labelled constituent, such as anti-IgE, for use in a specific binding assay method is disclosed. A labelled ligand, such as IgE, is standardized against a ligand reference substance, such as WHO standard IgE, to determine the weight of IgE protein represented by the labelled ligand. Anti-light chain antibodies are contacted with varying concentrations of the labelled ligand. The ligand is then contacted with the labelled constituent which is then quantitated in relation to the amount of ligand protein present. The preparation of 131I-labelled IgE is described. Also disclosed is an improved specific binding assay test method for determining the potency of an allergen extract in serum from an allergic individual. The improvement involved using a parallel model system of a second complex which consisted of anti-light chain antibodies, labelled ligand and the standardized labelled constituent (anti-IgE). The amount of standardized labelled constituent bound to the ligand in the first complex was determined, as described above, and the weight of ligand inhibited by addition of soluble allergen was then used as a measure of the potency of the allergen extract. (author)

Availability note (English)

MF available from INIS under the Report Number.

Files

11505216.pdf

Files (742.9 kB)

Name Size Download all
md5:b8d3177272830a352c8f1392f2049e41
742.9 kB Preview Download

Additional details

Publishing Information

Imprint Pagination
16 p.
IPC:
Int. Cl. G01n33/16; C07g7/00.
IPC
Int. Cl. G01n33/16; C07g7/00.
Patent number
GB patent document 2013337/A/